[Characterization of the acid-stable protease inhibitors in human plasma (author's transl)].
D000595:Amino Acid Sequence; D000596:Amino Acids / Q000032:analysis; D000818:Animals; D000937:Antigen-Antibody Reactions; D001665:Binding Sites; D001798:Blood Proteins / Q000302:isolation & purification / Q000494:pharmacology; D002417:Cattle; D002846:Chromatography, Affinity; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D002918:Chymotrypsin; D004140:Dinitrophenols; D004355:Drug Stability; D004791:Enzyme Inhibitors / Q000097:blood* / Q000276:immunology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007122:Immunoelectrophoresis; D008970:Molecular Weight; D011480:Protease Inhibitors; D011485:Protein Binding; D011817:Rabbits / Q000276:immunology; D013053:Spectrophotometry; D013056:Spectrophotometry, Ultraviolet; D014357:Trypsin; D000515:alpha 1-Antitrypsin / Q000276:immunology
D000596:Amino Acids; D001798:Blood Proteins; D004140:Dinitrophenols; D004791:Enzyme Inhibitors; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D002918:Chymotrypsin; D014357:Trypsin
Zur Charakterisierung der sürestabilen Proteaseninhibitoren aus Humanplasma